Global Study On Kaposi Sarcoma Market Size, Share, Trends, Growth and Forecast 2016 – Acute Market Reports

General Comments Off on Global Study On Kaposi Sarcoma Market Size, Share, Trends, Growth and Forecast 2016 – Acute Market Reports

Acute Market Reports, ‘Kaposi Sarcoma – Pipeline Review, H1 2016’, provides an overview of the Kaposi Sarcoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Kaposi Sarcoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Kaposi Sarcoma and features dormant and discontinued projects.

Browse Full Report Visit –

Acute Market Reports t features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Acute Market Reports proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Browse All Reports of This Category –

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.


– The report provides a snapshot of the global therapeutic landscape of Kaposi Sarcoma
– The report reviews pipeline therapeutics for Kaposi Sarcoma by companies and universities/research institutes based on information derived from company and industry-specific sources
– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
– The report reviews key players involved Kaposi Sarcoma therapeutics and enlists all their major and minor projects
– The report assesses Kaposi Sarcoma therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
– The report summarizes all the dormant and discontinued pipeline projects
– The report reviews latest news related to pipeline therapeutics for Kaposi Sarcoma

Reasons to buy

– Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of therapeutics under development for Kaposi Sarcoma
– Identify potential new clients or partners in the target demographic
– Develop strategic initiatives by understanding the focus areas of leading companies
– Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
– Devise corrective measures for pipeline projects by understanding Kaposi Sarcoma pipeline depth and focus of Indication therapeutics
– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
– Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Get Complete Report @ Kaposi Sarcoma – Pipeline Review, H1 2016

Table of Contents 2
List of Tables 5
List of Figures 5
Introduction 6
Global Markets Direct Report Coverage 6
Kaposi Sarcoma Overview 7
Therapeutics Development 8
Pipeline Products for Kaposi Sarcoma – Overview 8
Pipeline Products for Kaposi Sarcoma – Comparative Analysis 9
Kaposi Sarcoma – Therapeutics under Development by Companies 10
Kaposi Sarcoma – Therapeutics under Investigation by Universities/Institutes 11
Kaposi Sarcoma – Pipeline Products Glance 12
Clinical Stage Products 12
Early Stage Products 13
Unknown Stage Products 14
Kaposi Sarcoma – Products under Development by Companies 15
Kaposi Sarcoma – Products under Investigation by Universities/Institutes 16
Kaposi Sarcoma – Companies Involved in Therapeutics Development 17
Aphios Corporation 17
AstraZeneca Plc 18
Biogenomics Limited 19
CytRx Corporation 20
Delenex Therapeutics AG 21
Tumorend, LLC 22
Vironika, LLC 23
Kaposi Sarcoma – Therapeutics Assessment 24
Assessment by Monotherapy Products 24
Assessment by Target 25
Assessment by Mechanism of Action 27
Assessment by Route of Administration 29
Assessment by Molecule Type 31
Drug Profiles 33
aldoxorubicin hydrochloride – Drug Profile 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
brolucizumab – Drug Profile 36
Product Description 36
Mechanism of Action 36
R&D Progress 36
CM-101 – Drug Profile 39
Product Description 39
Mechanism of Action 39
R&D Progress 39
CSTATI-1 – Drug Profile 41
Product Description 41
Mechanism of Action 41
R&D Progress 41
doxorubicin – Drug Profile 43
Product Description 43
Mechanism of Action 43
R&D Progress 43
interferon alfa-2a – Drug Profile 44
Product Description 44
Mechanism of Action 44
R&D Progress 44
interferon alfa-2b – Drug Profile 45
Product Description 45
Mechanism of Action 45
R&D Progress 45
paclitaxel – Drug Profile 46
Product Description 46
Mechanism of Action 46
R&D Progress 46
selumetinib sulfate – Drug Profile 47
Product Description 47
Mechanism of Action 47
R&D Progress 47
Small Molecule for Kaposi’s Sarcoma – Drug Profile 51
Product Description 51
Mechanism of Action 51
R&D Progress 51
vif-1 – Drug Profile 52
Product Description 52
Mechanism of Action 52

Latest Reports :

Amyotrophic Lateral Sclerosis – Pipeline Review, H1 2016

Relapsed Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H1 2016

Hepatitis B – Pipeline Review, H1 2016
About – Acute Market Reports :

Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements.We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.

Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online.
Contact Us : 
Chris Paul
Office No 101, 1st Floor ,
Aditi Mall, Baner,
Pune, MH, 411045
Toll Free(US/CANADA): +1-855-455-8662
India: +91 7755981103
Email :
Website :


Back to Top